Moderna will seek approval for its Covid vaccine in the US and Europe

The American company Moderna announced that it will be ahead of emergency authorization requests next Monday covid-19 vaccine in United States and Europe, after full results confirmed the high efficacy (94.1%).

Two weeks after announcing a 94.5% efficacy based on preliminary results, Moderna reported that of the 196 clinical trial participants infected with COVID-19, 185 were in the placebo group and 11 in the vaccinated group, with a calculated efficiency of 94.1%.

No serious form of the disease was recorded in the vaccinated group.


Source link